KADAR b-hCG PENDERITA MOLA HIDATIDOSA SEBELUM DAN SESUDAH KURETASE

  • Syafii S
  • Aprianti S
  • Hardjoeno H
N/ACitations
Citations of this article
32Readers
Mendeley users who have this article in their library.

Abstract

Hydatiform mole is an important disease, with a high incidence, many risk factors, and equity spreading. To know and compareb-hCG levels among patients with hydatiform mole before and after curretage was investigated. A retrospective study from January2002 to December 2005 at Dr. Wahidin Sudirohusodo Public Hospital was performed comprising b-hCG levels of hydatiform molepatients before and after curettage. b-hCG level (Elisa's method) were grouped by age of pregnancy. Among 72 patients, 43 patients withhydatiform mole were found. At trimester I among 10 patients (23.3%), b-hCG level was higher 3 (7.0%), normally 4 (9.3%) and lower3 (7.0%). At trimester II, among 33 patients (76.7%), b-hCG level was higher 12 (27.9%), normal 13 (30.2%) and lower 3 (7.0%).After curretage, b-hCG level was decreased in 35 (81.4%), and increased in 7 (16.3%). Diagnosis of hydatiform mole was establishedin 36 (83.7%) and Gestational Trophoblastic Tumours (GTT) 7 (16.3%). Patients with hydatiform mole had the highest incidence intrimester II with normal b-hCG level and b-hCG level decreased after curretage.

Cite

CITATION STYLE

APA

Syafii, S., Aprianti, S., & Hardjoeno, H. (2018). KADAR b-hCG PENDERITA MOLA HIDATIDOSA SEBELUM DAN SESUDAH KURETASE. INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY, 13(1), 1–3. https://doi.org/10.24293/ijcpml.v13i1.877

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free